About this trial
This clinical trial compares two smartphone applications, called Actify! (A \& B) for improving smoking cessation outcomes in individuals who smoke. Actify! A is an app grounded in behavioral activation therapy, an evidence-based treatment for depression that can also be used to modify health behaviors such as smoking. The Actify! B app provides evidence-based tobacco cessation strategies based on current clinical guidelines.
Eligibility criteria
Qualifiers
Age 18 or older
Currently smoke, averaging at least 5 cigarettes/day for the last 30 days
Interested in quitting smoking in the next 30 days
Experience downloading and using one or more apps on their smartphone
Disqualifiers
Self-report of currently receiving behavioral treatment for depression (e.g., psychotherapy or counseling, web- or app-based interventions); current use of pharmacotherapy for depression or for other mental health conditions that are not otherwise excluded is allowable (e.g., benzodiazepines, anticonvulsants, opioid agonists, antipsychotics)
Severe depression (PHQ-9 ≥ 20)
Current suicidal ideation reported on the PHQ-9
History of a suicide attempt
Trial design
Treatments tested in this trial
- Smartphone app-based Intervention (Actify! A app)
- Smartphone app-based Intervention (Actify! B app)
- Health Promotion and Education
- Survey Administration
Treatment groups
Sponsors and collaborators
Fred Hutchinson Cancer Center
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator